4.1.2022
•
News
Tomáš Sequens Named New KSB Partner
As of 1 January 2022, KSB counsel Tomáš Sequens became a new partner.
Tomáš has been an attorney-at-law since 2003 and focuses primarily on energy, mining and minerals, and environmental law. He is regularly recommended by international rating agencies such as Chambers & Partners and Legal500 as one of the leading Czech specialists in energy law.
“Tomáš is well placed to become a partner at KSB thanks to his professional and personal character, as well as his long and successful tenure at our law firm, which has significantly contributed to building KSB’s reputation. We look forward to working with him in his new role and wish him and KSB every success." said Petr Kasík, KSB Managing Partner.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
